drugset
drugset / Trial / NCT02760823

Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning

NCT02760823 ↗

Phase 2 Unknown 50 enrolled Heba Allah Ali Abd El-Halim Mabrouk Tanta University · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to evaluate efficacy and safety of Alpha Lipoic Acid(ALA) as an adjuvant in the management of patients with acute phosphide poisoning.

Timeline

Start
2016-05
Primary completion
2018-01
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-lipoic acid Small molecule 600 mg Intravenous

Indications

poisoning